Preferred Label : Imfinzi;
Origin ID : M000642649;
Related record
- See also inter- (CISMeF)
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet
---
https://www.has-sante.fr/jcms/p_3506840/fr/imfinzi-durvalumab-cancer-bronchique-non-a-petites-cellules
2024
false
false
false
France
evaluation of the transparency committee
Imfinzi
Durvalumab
durvalumab
durvalumab
---
https://pgtmsite.files.wordpress.com/2024/01/mic_-durvalumab_ce-1.pdf
2021
false
false
false
Canada
evaluation of the transparency committee
body weight
methyl isocyanate
durvalumab
durvalumab
Imfinzi
microbial sensitivity tests
hospitals, proprietary
---
